Login

Cyclo Therapeutics, Inc. 4 SEC Filings

Filed On Filing
03 Mar 2025 Form 4: Conkling William, Director

Received 27,654 shares as a grant or award

03 Mar 2025 Form 4: Wong Vivien, Director

Received 25,140 shares as a grant or award

03 Mar 2025 Form 4: Cross Shawn, Director

Received 28,597 shares as a grant or award

03 Mar 2025 Form 4: Toig Randall M., Director

Received 33,311 shares as a grant or award

03 Mar 2025 Form 4: Strattan Ce Rick, Director

Received 30,169 shares as a grant or award

03 Mar 2025 Form 4: Ostronic Francis Patrick, Director

Received 70,329 shares as a grant or award

03 Mar 2025 Form 4: Sieger Markus, Director

Received 58,138 shares as a grant or award

28 Feb 2025 Form 4: Shanahan William S, Director

Received 25,140 shares as a grant or award

13 Jan 2025 Form 4: Rafael Holdings, Inc., 10% owner

Received 3,968,254 shares by conversion ($2.5M)

18 Nov 2024 Form 4: Conkling William, Director

Received 16,660 shares as a grant or award

18 Nov 2024 Form 4: Cross Shawn, Director

Received 17,228 shares as a grant or award

18 Nov 2024 Form 4: Shanahan William S, Director

Received 15,145 shares as a grant or award

18 Nov 2024 Form 4: Sieger Markus, Director

Received 35,022 shares as a grant or award

18 Nov 2024 Form 4: Strattan Ce Rick, Director

Received 63,608 shares as a grant or award

18 Nov 2024 Form 4: Toig Randall M., Director

Received 20,067 shares as a grant or award

18 Nov 2024 Form 4: Wong Vivien, Director

Received 15,145 shares as a grant or award

20 Aug 2024 Form 4: Shanahan William S, Director

Received 7,937 shares as a grant or award

20 Aug 2024 Form 4: Conkling William, Director

Received 8,731 shares as a grant or award

20 Aug 2024 Form 4: Wong Vivien, Director

Received 7,937 shares as a grant or award

20 Aug 2024 Form 4: Cross Shawn, Director

Received 9,028 shares as a grant or award

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support